Brief: Viva Biotech Sees Significant Amount Of Net Loss During Year
16/03/2021 15:13
March 16 (Reuters) - VIVA Biotech Holdings 1873.HK :
* VIVA BIOTECH HOLDINGS SEES SIGNIFICANT AMOUNT OF NET LOSS
DURING YEAR
* VIVA BIOTECH HOLDINGS SEES REVENUE TO INCREASE BY OVER
100% FOR
YEAR
* VIVA BIOTECH - EXPECTED LOSS DUE TO EXTRAORDINARY LOSS
OF
ABOUT RMB600 MILLION IN RELATION TO CONVERTIBLE BONDS ISSUED IN
COMPLIANCE WITH IFRS
Source text for Eikon: urn:newsml:reuters.com:*:nHKS7Ty857
Further company coverage: 1873.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VIVA Biotech Holdings
See all newsVIVA Biotech H1 profit falls on weaker investment income, FX headwinds
Brief: Viva Biotech Posts FY Net Profit RMB269.3 Million
Brief: Viva Biotech Received Declaration Letter
Brief: Viva Biotech Says Hangzhou Viva Zongchen Agreed To Invest RMB25.0 Million To Fund
Brief: Viva Biotech Passing Of U.S. FDA On-Site Inspection By Langhua Pharmaceutical